Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Chinese Academy of Medical Sciences.
Recruitment status was  Recruiting
Study NCT01276769   Information provided by Chinese Academy of Medical Sciences

First Received on December 10, 2010.   Last Updated on November 15, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial